Disc Medicine, Inc. (IRON) income statement
IRONNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$76.11−1.87 (-2.40%)
Close on Nov 19, 2026Market cap $2.92BP/E –Yield –
Disc Medicine, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -35.9%
Financial strength
- Current ratio
- 24.14
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 325.0%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 4.54
- Dividend yield
- –
See a number that looks wrong?